Perlegen to Identify Heart Attack Gene Variants for AstraZeneca | GenomeWeb

NEW YORK, Jan. 9  (GenomeWeb News) - Perlegen Sciences and AstraZeneca will collaborate in a study that aims to find gene variants that increase the risk for heart attack, Perlegen said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.